SEBREE TERRI B (President) sold 6.7% of their position (24.66K shares) of ZYNERBA PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $14.7K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/25/2023ACC: 0001062993-23-001387
Officer· President
Since Aug 2018
+145.34K
Net shares
Net buyer
$14.7K
Total sold
1
Open market trades
0B · 1S
2
Total transactions
170K acquired · 24.66K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−24.66K
Price / share
$0.60
Trade value
$14.74K
% of position
6.7%
1/23/2023
367.87K→343.20K
Common Stock
Direct
Shares
+170K
Price / share
—
Trade value
—
% of position
49.5%
1/24/2023
343.20K→513.20K
Total
Net shares
+145.34K
Net value
-$14.74K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/23/2023 | S · Sale | −24.66K | $0.60 | $14.74K | 6.7% | 367.87K | 343.20K |
| Common Stock Direct | 1/24/2023 | A · Award | +170K | — | — | 49.5% | 343.20K | 513.20K |
| Total | +145.34K | -$14.74K | ||||||
Derivative Transactions0
No derivative transactions reported